Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation in bullous skin diseases.

R E Jordon

    The Journal of Investigative Dermatology
    |July 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    The complement system plays a role in chronic blistering skin diseases like pemphigus and bullous pemphigoid. Different pathways of complement activation are implicated in their distinct immunopathogenesis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cryofibrinogenemia in a patient with B-cell lymphoma.

    Clinical lymphoma·2001
    Same author

    A progressive blistering eruption in a patient with lymphoma. Paraneoplastic pemphigus.

    Archives of dermatology·1997
    Same author

    Systemic lupus erythematosus diagnosed during interferon alfa therapy.

    Southern medical journal·1996
    Same author

    Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies.

    The Journal of investigative dermatology·1996
    Same author

    Neonatal pemphigus foliaceus.

    Archives of dermatology·1995
    Same author

    Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy.

    Archives of dermatology·1992
    Same journal

    Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

    The Journal of investigative dermatology·2026
    Same journal

    Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

    The Journal of investigative dermatology·2026
    Same journal

    Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

    The Journal of investigative dermatology·2026
    Same journal

    Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

    The Journal of investigative dermatology·2026
    Same journal

    The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

    The Journal of investigative dermatology·2026
    Same journal

    Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial.

    The Journal of investigative dermatology·2026
    See all related articles

    Area of Science:

    • Immunodermatology
    • Complement System Biology

    Background:

    • Chronic vesiculobullous skin diseases include pemphigus, bullous pemphigoid, cicatricial pemphigoid, dermatitis herpetiformis, and herpes gestationis.
    • The complement system, comprising classical and alternative pathways, is increasingly recognized for its role in inflammatory skin conditions.

    Purpose of the Study:

    • To investigate the involvement of the complement system, including both classical and alternative pathways, in the pathogenesis of various chronic vesiculobullous skin diseases.
    • To elucidate the specific immunopathologic findings related to complement activation in these conditions.

    Main Methods:

    • Analysis of complement component activation (C1, C4, C2, C3, C5, properdin) in patient samples.
    • Immunohistochemical and immunofluorescence studies to identify complement deposition and activation markers.

    Related Experiment Videos

  • Correlation of complement activation patterns with clinical and histopathological features.

    • Main Results:

    • Pemphigus exhibits activation of early (C1, C4, C2) and late (C3, C5) complement components, suggesting classical pathway involvement.
    • Bullous pemphigoid and cicatricial pemphigoid show evidence of both classical and alternative pathway activation, indicated by properdin and early component participation.
    • Herpes gestationis and dermatitis herpetiformis may primarily involve the alternative or properdin pathway for complement activation.

    Conclusions:

    • The complement system is critically involved in the pathogenesis of chronic vesiculobullous skin diseases.
    • Distinct patterns of complement pathway activation differentiate these diseases, offering insights into their specific immunopathogenesis.
    • Understanding these complement-mediated mechanisms is crucial for developing targeted therapies.